{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:39:23Z","timestamp":1790959163612,"version":"4.1.0"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:00:00Z","timestamp":1721433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:00:00Z","timestamp":1721433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004702","name":"Universit\u00e0 degli Studi di Genova","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004702","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>This position statement by the Italian Society of Fertility and Sterility and Reproductive Medicine (SIFES-MR) aims to establish an optimal framework for fertility preservation outside the standard before oncological therapies. Key topics include the role of fertility units in comprehensive fertility assessment, factors impacting ovarian potential, available preservation methods, and appropriate criteria for offering such interventions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The SIFES-MR writing group comprises Italian reproductive physicians, embryologists, and scientists. The consensus emerged after a six-month period of meetings, including extensive literature review, dialogue among authors and input from society members. Final approval was granted by the SIFES-MR governing council.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Fertility counselling transitions from urgent to long-term care, emphasizing family planning. Age, along with ovarian reserve markers, is the primary predictor of female fertility. Various factors, including gynecological conditions, autoimmune disorders, and prior gonadotoxic therapies, may impact ovarian reserve. Oocyte cryopreservation should be the preferred method. Women 30\u201334 years old and 35\u201339 years old, without known pathologies impacting the ovarian reserve, should cryopreserve at least 12\u201313 and 15\u201320 oocytes to achieve the same chance of a spontaneous live birth they would have if they tried to conceive at the age of cryopreservation (63% and 52%, respectively in the two age groups).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Optimal fertility counselling necessitates a long-term approach, that nurtures an understanding of fertility, facilitates timely evaluation of factors that may affect fertility, and explores fertility preservation choices at opportune intervals.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10815-024-03197-4","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T03:26:56Z","timestamp":1721446016000},"page":"2521-2535","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Female fertility preservation for family planning: a position statement of the Italian Society of Fertility and Sterility and Reproductive Medicine (SIFES-MR)"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1905-2786","authenticated-orcid":false,"given":"Claudia","family":"Massarotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Cimadomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Spadoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Conforti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Zac\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Roberto","family":"Carosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Vaiarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Venturella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amerigo","family":"Vitagliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Busnelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Cozzolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Borini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,20]]},"reference":[{"key":"3197_CR1","unstructured":"ISTAT. Indicatori demografici, anno 2023. 2023. [Online]. Available: https:\/\/www.istat.it\/it\/files\/\/2023\/12\/CENSIMENTOEDINAMICADEMOGRAFICA2022.pdf. Accessed 20 Jan 2024."},{"key":"3197_CR2","doi-asserted-by":"publisher","unstructured":"European IVF Monitoring Consortium (EIM), for the European Society of Human Reproduction and Embryology (ESHRE), et al. ART in Europe, 2018: results generated from European registries by ESHRE. Hum Reprod Open. 2022;2022(3): hoac022. https:\/\/doi.org\/10.1093\/hropen\/hoac022.","DOI":"10.1093\/hropen\/hoac022"},{"issue":"2","key":"3197_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/14647273.2019.1570354","volume":"24","author":"JC Harper","year":"2021","unstructured":"Harper JC, et al. Feasibility and acceptability of theatrical and visual art to deliver fertility education to young adults. Hum Fertil Camb Engl. 2021;24(2):129\u201335. https:\/\/doi.org\/10.1080\/14647273.2019.1570354.","journal-title":"Hum Fertil Camb Engl"},{"issue":"5","key":"3197_CR4","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.fertnstert.2013.07.201","volume":"100","author":"B Hodes-Wertz","year":"2013","unstructured":"Hodes-Wertz B, Druckenmiller S, Smith M, Noyes N. What do reproductive-age women who undergo oocyte cryopreservation think about the process as a means to preserve fertility? Fertil Steril. 2013;100(5):1343\u20139. https:\/\/doi.org\/10.1016\/j.fertnstert.2013.07.201.","journal-title":"Fertil Steril"},{"key":"3197_CR5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3389\/fendo.2018.00327","volume":"9","author":"D Cimadomo","year":"2018","unstructured":"Cimadomo D, Fabozzi G, Vaiarelli A, Ubaldi N, Ubaldi FM, Rienzi L. Impact of maternal age on oocyte and embryo competence. Front Endocrinol. 2018;9:327. https:\/\/doi.org\/10.3389\/fendo.2018.00327.","journal-title":"Front Endocrinol"},{"issue":"6","key":"3197_CR6","doi-asserted-by":"publisher","first-page":"Art. no. 6","DOI":"10.1093\/humupd\/dml034","volume":"12","author":"FJ Broekmans","year":"2006","unstructured":"Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006;12(6):Art. no. 6. https:\/\/doi.org\/10.1093\/humupd\/dml034.","journal-title":"Hum Reprod Update"},{"issue":"3","key":"3197_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.18502\/jri.v24i3.13274","volume":"24","author":"CM Miller","year":"2023","unstructured":"Miller CM, Melikian REM, Jones TL, Purdy MP, Khan Z, Bleess JL, Stewart EA, Coddington CC, Shenoy CC. Follicle Stimulating Hormone (FSH) as a Predictor of Decreased Oocyte Yield in Patients with Normal Anti-M\u00fcllerian Hormone (AMH) and Antral Follicle Count (AFC). J Reprod Infertil. 2023;24(3):181\u20137. https:\/\/doi.org\/10.18502\/jri.v24i3.13274.","journal-title":"J Reprod Infertil"},{"issue":"4","key":"3197_CR8","doi-asserted-by":"publisher","first-page":"Art. no. 4","DOI":"10.1515\/cclm-2021-0698","volume":"60","author":"M Biniasch","year":"2022","unstructured":"Biniasch M, Laubender RP, Hund M, Buck K, De Geyter C. Intra- and inter-cycle variability of anti-M\u00fcllerian hormone (AMH) levels in healthy women during non-consecutive menstrual cycles: the BICYCLE study. Clin Chem Lab Med. 2022;60(4):Art. no. 4. https:\/\/doi.org\/10.1515\/cclm-2021-0698.","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"3197_CR9","doi-asserted-by":"publisher","first-page":"Art. no. 1","DOI":"10.1186\/s13048-023-01202-5","volume":"16","author":"Y Liu","year":"2023","unstructured":"Liu Y, Pan Z, Wu Y, Song J, Chen J. Comparison of anti-M\u00fcllerian hormone and antral follicle count in the prediction of ovarian response: a systematic review and meta-analysis. J Ovarian Res. 2023;16(1):Art. no. 1. https:\/\/doi.org\/10.1186\/s13048-023-01202-5.","journal-title":"J Ovarian Res"},{"key":"3197_CR10","doi-asserted-by":"publisher","first-page":"1162015","DOI":"10.3389\/fcell.2023.1162015","volume":"11","author":"S Dutta","year":"2023","unstructured":"Dutta S, et al. Reproductive toxicity of combined effects of endocrine disruptors on human reproduction. Front Cell Dev Biol. 2023;11:1162015. https:\/\/doi.org\/10.3389\/fcell.2023.1162015.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"3197_CR11","doi-asserted-by":"publisher","first-page":"Art. no. 1","DOI":"10.1093\/humupd\/dmq033","volume":"17","author":"C Dechanet","year":"2011","unstructured":"Dechanet C, et al. Effects of cigarette smoking on reproduction. Hum Reprod Update. 2011;17(1):Art. no. 1. https:\/\/doi.org\/10.1093\/humupd\/dmq033.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"3197_CR12","doi-asserted-by":"publisher","first-page":"Art. no. 1","DOI":"10.1186\/s12958-020-0567-7","volume":"18","author":"C de Angelis","year":"2020","unstructured":"de Angelis C, et al. Smoke, alcohol and drug addiction and female fertility. Reprod Biol Endocrinol RBE. 2020;18(1):Art. no. 1. https:\/\/doi.org\/10.1186\/s12958-020-0567-7.","journal-title":"Reprod Biol Endocrinol RBE"},{"issue":"7","key":"3197_CR13","doi-asserted-by":"publisher","first-page":"Art. no. 7","DOI":"10.2217\/epi-2023-0064","volume":"15","author":"JO Lo","year":"2023","unstructured":"Lo JO, D\u2019Mello RJ, Watch L, Schust DJ, Murphy SK. An epigenetic synopsis of parental substance use. Epigenomics. 2023;15(7):Art. no. 7. https:\/\/doi.org\/10.2217\/epi-2023-0064.","journal-title":"Epigenomics"},{"issue":"2","key":"3197_CR14","doi-asserted-by":"publisher","first-page":"Art. no. 2","DOI":"10.1016\/j.taap.2014.02.009","volume":"276","author":"W Wang","year":"2014","unstructured":"Wang W, Hafner KS, Flaws JA. In utero bisphenol A exposure disrupts germ cell nest breakdown and reduces fertility with age in the mouse. Toxicol Appl Pharmacol. 2014;276(2):Art. no. 2. https:\/\/doi.org\/10.1016\/j.taap.2014.02.009.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"3197_CR15","doi-asserted-by":"publisher","first-page":"hoad012","DOI":"10.1093\/hropen\/hoad012","volume":"2023","author":"P Santulli","year":"2023","unstructured":"Santulli P, et al. Fertility preservation in women with benign gynaecological conditions. Hum Reprod Open. 2023;2023(2):hoad012. https:\/\/doi.org\/10.1093\/hropen\/hoad012.","journal-title":"Hum Reprod Open"},{"issue":"2","key":"3197_CR16","doi-asserted-by":"publisher","first-page":"Art. no. 2","DOI":"10.1016\/j.ajog.2006.03.064","volume":"195","author":"M Busacca","year":"2006","unstructured":"Busacca M, et al. Postsurgical ovarian failure after laparoscopic excision of bilateral endometriomas. Am J Obstet Gynecol. 2006;195(2):Art. no. 2. https:\/\/doi.org\/10.1016\/j.ajog.2006.03.064.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"3197_CR17","doi-asserted-by":"publisher","first-page":"Art. no. 3","DOI":"10.1093\/humrep\/den398","volume":"24","author":"JA Garcia-Velasco","year":"2009","unstructured":"Garcia-Velasco JA, Somigliana E. Management of endometriomas in women requiring IVF: to touch or not to touch. Hum Reprod Oxf Engl. 2009;24(3):Art. no. 3. https:\/\/doi.org\/10.1093\/humrep\/den398.","journal-title":"Hum Reprod Oxf Engl"},{"issue":"8","key":"3197_CR18","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1093\/humrep\/det123","volume":"28","author":"G Uncu","year":"2013","unstructured":"Uncu G, Kasapoglu I, Ozerkan K, Seyhan A, Oral Yilmaztepe A, Ata B. Prospective assessment of the impact of endometriomas and their removal on ovarian reserve and determinants of the rate of decline in ovarian reserve. Hum Reprod Oxf Engl. 2013;28(8):2140\u20135. https:\/\/doi.org\/10.1093\/humrep\/det123.","journal-title":"Hum Reprod Oxf Engl"},{"issue":"11","key":"3197_CR19","doi-asserted-by":"publisher","first-page":"Art. no. 11","DOI":"10.1210\/jc.2019-00281","volume":"104","author":"A Takeuchi","year":"2019","unstructured":"Takeuchi A, et al. Endometriosis triggers excessive activation of primordial follicles via PI3K-PTEN-Akt-Foxo3 pathway. J Clin Endocrinol Metab. 2019;104(11):Art. no. 11. https:\/\/doi.org\/10.1210\/jc.2019-00281.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"3197_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/humupd\/dmt053","volume":"20","author":"AM Sanchez","year":"2014","unstructured":"Sanchez AM, Vigan\u00f2 P, Somigliana E, Panina-Bordignon P, Vercellini P, Candiani M. The distinguishing cellular and molecular features of the endometriotic ovarian cyst: from pathophysiology to the potential endometrioma-mediated damage to the ovary. Hum Reprod Update. 2014;20(2):217\u201330. https:\/\/doi.org\/10.1093\/humupd\/dmt053.","journal-title":"Hum Reprod Update"},{"issue":"4","key":"3197_CR21","doi-asserted-by":"publisher","first-page":"Art. no. 4","DOI":"10.1016\/j.fertnstert.2019.11.017","volume":"113","author":"A Cobo","year":"2020","unstructured":"Cobo A, Giles J, Paolelli S, Pellicer A, Remoh\u00ed J, Garc\u00eda-Velasco JA. Oocyte vitrification for fertility preservation in women with endometriosis: an observational study. Fertil Steril. 2020;113(4):Art. no. 4. https:\/\/doi.org\/10.1016\/j.fertnstert.2019.11.017.","journal-title":"Fertil Steril"},{"key":"3197_CR22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ejogrb.2020.11.024","volume":"256","author":"A Vaiarelli","year":"2021","unstructured":"Vaiarelli A, et al. Endometriosis shows no impact on the euploid blastocyst rate per cohort of inseminated metaphase-II oocytes: a case-control study. Eur J Obstet Gynecol Reprod Biol. 2021;256:205\u201310. https:\/\/doi.org\/10.1016\/j.ejogrb.2020.11.024.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"3197_CR23","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.rbmo.2020.12.013","volume":"42","author":"A Cobo","year":"2021","unstructured":"Cobo A, et al. Number needed to freeze: cumulative live birth rate after fertility preservation in women with endometriosis. Reprod Biomed Online. 2021;42(4):725\u201332. https:\/\/doi.org\/10.1016\/j.rbmo.2020.12.013.","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"3197_CR24","doi-asserted-by":"publisher","first-page":"Art. no. 2","DOI":"10.1016\/j.jpag.2022.11.006","volume":"36","author":"ME Knaus","year":"2023","unstructured":"Knaus ME, et al. Recurrence rates for pediatric benign ovarian neoplasms. J Pediatr Adolesc Gynecol. 2023;36(2):Art. no. 2. https:\/\/doi.org\/10.1016\/j.jpag.2022.11.006.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"12","key":"3197_CR25","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1111\/jog.15409","volume":"48","author":"D Atwi","year":"2022","unstructured":"Atwi D, Kamal M, Quinton M, Hassell LA. Malignant transformation of mature cystic teratoma of the ovary. J Obstet Gynaecol Res. 2022;48(12):3068\u201376. https:\/\/doi.org\/10.1111\/jog.15409.","journal-title":"J Obstet Gynaecol Res"},{"issue":"5","key":"3197_CR26","doi-asserted-by":"publisher","first-page":"Art. no. 5","DOI":"10.7759\/cureus.8094","volume":"12","author":"F Angum","year":"2020","unstructured":"Angum F, Khan T, Kaler J, Siddiqui L, Hussain A. The prevalence of autoimmune disorders in women: a narrative review. Cureus. 2020;12(5):Art. no. 5. https:\/\/doi.org\/10.7759\/cureus.8094.","journal-title":"Cureus"},{"issue":"6","key":"3197_CR27","doi-asserted-by":"publisher","first-page":"Art. no. 6","DOI":"10.1016\/j.beem.2019.101369","volume":"33","author":"J Khizroeva","year":"2019","unstructured":"Khizroeva J, et al. Infertility in women with systemic autoimmune diseases. Best Pract Res Clin Endocrinol Metab. 2019;33(6):Art. no. 6. https:\/\/doi.org\/10.1016\/j.beem.2019.101369.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"3197_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bpobgyn.2019.11.004","volume":"64","author":"EC Somers","year":"2020","unstructured":"Somers EC. Pregnancy and autoimmune diseases. Best Pract Res Clin Obstet Gynaecol. 2020;64:3\u201310. https:\/\/doi.org\/10.1016\/j.bpobgyn.2019.11.004.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"12","key":"3197_CR29","doi-asserted-by":"publisher","first-page":"Art. no. 12","DOI":"10.1002\/art.39311","volume":"67","author":"JS Chen","year":"2015","unstructured":"Chen JS, Roberts CL, Simpson JM, March LM. Pregnancy outcomes in women with rare autoimmune diseases. Arthritis Rheumatol Hoboken NJ. 2015;67(12):Art. no. 12. https:\/\/doi.org\/10.1002\/art.39311.","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"1","key":"3197_CR30","doi-asserted-by":"publisher","first-page":"Art. no. 1","DOI":"10.1038\/nrendo.2013.212","volume":"10","author":"A Sen","year":"2014","unstructured":"Sen A, Kushnir VA, Barad DH, Gleicher N. Endocrine autoimmune diseases and female infertility. Nat Rev Endocrinol. 2014;10(1):Art. no. 1. https:\/\/doi.org\/10.1038\/nrendo.2013.212.","journal-title":"Nat Rev Endocrinol"},{"key":"3197_CR31","doi-asserted-by":"publisher","first-page":"iii38","DOI":"10.1093\/rheumatology\/ken156","volume":"47 Suppl 3","author":"M Costa","year":"2008","unstructured":"Costa M, Colia D. Treating infertility in autoimmune patients. Rheumatol Oxf Engl. 2008;47 Suppl 3:iii38-41. https:\/\/doi.org\/10.1093\/rheumatology\/ken156.","journal-title":"Rheumatol Oxf Engl"},{"issue":"5","key":"3197_CR32","doi-asserted-by":"publisher","first-page":"Art. no. 5","DOI":"10.3390\/ijms22052594","volume":"22","author":"A Szeliga","year":"2021","unstructured":"Szeliga A, et al. Autoimmune diseases in patients with premature ovarian insufficiency-our current state of knowledge. Int J Mol Sci. 2021;22(5):Art. no. 5. https:\/\/doi.org\/10.3390\/ijms22052594.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"3197_CR33","doi-asserted-by":"publisher","first-page":"Art. no. 6","DOI":"10.4137\/CMRH.S10415","volume":"2012","author":"W Marder","year":"2012","unstructured":"Marder W, Fisseha S, Ganser MA, Somers EC. Ovarian damage during chemotherapy in autoimmune diseases: broad health implications beyond fertility. Clin Med Insights Reprod Health. 2012;2012(6):Art. no. 6. https:\/\/doi.org\/10.4137\/CMRH.S10415.","journal-title":"Clin Med Insights Reprod Health"},{"issue":"5","key":"3197_CR34","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1080\/14397595.2020.1856020","volume":"31","author":"Y Tsuchida","year":"2021","unstructured":"Tsuchida Y, et al. Fertility preservation in patients receiving gonadotoxic therapies for systemic autoimmune diseases in Japan. Mod Rheumatol. 2021;31(5):1004\u20139. https:\/\/doi.org\/10.1080\/14397595.2020.1856020.","journal-title":"Mod Rheumatol"},{"issue":"13","key":"3197_CR35","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1177\/13524585211000616","volume":"27","author":"C Massarotti","year":"2021","unstructured":"Massarotti C, et al. Menstrual cycle resumption and female fertility after autologous hematopoietic stem cell transplantation for multiple sclerosis. Mult Scler Houndmills Basingstoke Engl. 2021;27(13):2103\u20137. https:\/\/doi.org\/10.1177\/13524585211000616.","journal-title":"Mult Scler Houndmills Basingstoke Engl"},{"key":"3197_CR36","doi-asserted-by":"publisher","first-page":"102287","DOI":"10.1016\/j.jaut.2019.05.015","volume":"103","author":"A Williams","year":"2019","unstructured":"Williams A, et al. Obstetric and neonatal complications among women with autoimmune disease. J Autoimmun. 2019;103:102287. https:\/\/doi.org\/10.1016\/j.jaut.2019.05.015.","journal-title":"J Autoimmun"},{"issue":"10","key":"3197_CR37","doi-asserted-by":"publisher","first-page":"102901","DOI":"10.1016\/j.autrev.2021.102901","volume":"20","author":"IJ Walter","year":"2021","unstructured":"Walter IJ, Klein Haneveld MJ, Lely AT, Bloemenkamp KWM, Limper M, Kooiman J. Pregnancy outcome predictors in antiphospholipid syndrome: a systematic review and meta-analysis. Autoimmun Rev. 2021;20(10):102901. https:\/\/doi.org\/10.1016\/j.autrev.2021.102901.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"3197_CR38","doi-asserted-by":"publisher","first-page":"Art. no. 2","DOI":"10.5312\/wjo.v5.i2.107","volume":"5","author":"AG Tristano","year":"2014","unstructured":"Tristano AG. Impact of rheumatoid arthritis on sexual function. World J Orthop. 2014;5(2):Art. no. 2. https:\/\/doi.org\/10.5312\/wjo.v5.i2.107.","journal-title":"World J Orthop"},{"issue":"4","key":"3197_CR39","doi-asserted-by":"publisher","first-page":"Art. no. 4","DOI":"10.1093\/humupd\/dmz014","volume":"25","author":"N Shigesi","year":"2019","unstructured":"Shigesi N, et al. The association between endometriosis and autoimmune diseases: a systematic review and meta-analysis. Hum Reprod Update. 2019;25(4):Art. no. 4. https:\/\/doi.org\/10.1093\/humupd\/dmz014.","journal-title":"Hum Reprod Update"},{"key":"3197_CR40","doi-asserted-by":"publisher","unstructured":"ESHRE Guideline Group on Female Fertility Preservation, et al. ESHRE guideline: female fertility preservation. Hum Reprod Open. 2020;2020(4): Art. no. 4. https:\/\/doi.org\/10.1093\/hropen\/hoaa052.","DOI":"10.1093\/hropen\/hoaa052"},{"key":"3197_CR41","doi-asserted-by":"publisher","unstructured":"ESHRE PGT Consortium Steering Committee, et al. ESHRE PGT Consortium good practice recommendations for the organisation of PGT. Hum Reprod Open. 2020;2020(3):hoaa021. https:\/\/doi.org\/10.1093\/hropen\/hoaa021.","DOI":"10.1093\/hropen\/hoaa021"},{"issue":"2","key":"3197_CR42","doi-asserted-by":"publisher","first-page":"Art. no. 2","DOI":"10.1530\/EJE-13-0900","volume":"170","author":"A Gawlik","year":"2014","unstructured":"Gawlik A, Malecka-Tendera E. Transitions in endocrinology: treatment of Turner\u2019s syndrome during transition. Eur J Endocrinol. 2014;170(2):Art. no. 2. https:\/\/doi.org\/10.1530\/EJE-13-0900.","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"3197_CR43","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1093\/humrep\/dew012","volume":"31","author":"V Bernard","year":"2016","unstructured":"Bernard V, et al. Spontaneous fertility and pregnancy outcomes amongst 480 women with Turner syndrome. Hum Reprod Oxf Engl. 2016;31(4):782\u20138. https:\/\/doi.org\/10.1093\/humrep\/dew012.","journal-title":"Hum Reprod Oxf Engl"},{"issue":"6","key":"3197_CR44","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/j.1399-0004.1983.tb00097.x","volume":"24","author":"R Sarkar","year":"1983","unstructured":"Sarkar R, Marimuthu KM. Association between the degree of mosaicism and the severity of syndrome in Turner mosaics and Klinefelter mosaics. Clin Genet. 1983;24(6):420\u20138. https:\/\/doi.org\/10.1111\/j.1399-0004.1983.tb00097.x.","journal-title":"Clin Genet"},{"issue":"11","key":"3197_CR45","doi-asserted-by":"publisher","first-page":"Art. no. 11","DOI":"10.1210\/jc.2010-0930","volume":"95","author":"CP Hagen","year":"2010","unstructured":"Hagen CP, et al. Serum levels of anti-M\u00fcllerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients. J Clin Endocrinol Metab. 2010;95(11):Art. no. 11. https:\/\/doi.org\/10.1210\/jc.2010-0930.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"3197_CR46","doi-asserted-by":"publisher","first-page":"Art. no. 9","DOI":"10.1002\/ajmg.a.40473","volume":"176","author":"RT Hamza","year":"2018","unstructured":"Hamza RT, Mira MF, Hamed AI, Ezzat T, Sallam MT. Anti-M\u00fcllerian hormone levels in patients with turner syndrome: relation to karyotype, spontaneous puberty, and replacement therapy. Am J Med Genet A. 2018;176(9):Art. no. 9. https:\/\/doi.org\/10.1002\/ajmg.a.40473.","journal-title":"Am J Med Genet A"},{"issue":"2","key":"3197_CR47","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1093\/humrep\/dem307","volume":"23","author":"JYJ Huang","year":"2008","unstructured":"Huang JYJ, et al. Cryopreservation of ovarian tissue and in vitro matured oocytes in a female with mosaic Turner syndrome: case report. Hum Reprod Oxf Engl. 2008;23(2):336\u20139. https:\/\/doi.org\/10.1093\/humrep\/dem307.","journal-title":"Hum Reprod Oxf Engl"},{"issue":"6","key":"3197_CR48","doi-asserted-by":"publisher","first-page":"Art. no. 6","DOI":"10.1016\/j.jpag.2014.01.003","volume":"27","author":"K Oktay","year":"2014","unstructured":"Oktay K, Bedoschi G. Oocyte cryopreservation for fertility preservation in postpubertal female children at risk for premature ovarian failure due to accelerated follicle loss in Turner syndrome or cancer treatments. J Pediatr Adolesc Gynecol. 2014;27(6):Art. no. 6. https:\/\/doi.org\/10.1016\/j.jpag.2014.01.003.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"5","key":"3197_CR49","doi-asserted-by":"publisher","first-page":"Art. no. 5","DOI":"10.1016\/j.jpag.2015.10.011","volume":"29","author":"K Oktay","year":"2016","unstructured":"Oktay K, et al. Fertility preservation in women with turner syndrome: a comprehensive review and practical guidelines. J Pediatr Adolesc Gynecol. 2016;29(5):Art. no. 5. https:\/\/doi.org\/10.1016\/j.jpag.2015.10.011.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"2","key":"3197_CR50","doi-asserted-by":"publisher","first-page":"Art. no. 2","DOI":"10.1016\/j.fertnstert.2011.11.049","volume":"97","author":"Practice Committee of American Society for Reproductive Medicine","year":"2012","unstructured":"Practice Committee of American Society for Reproductive Medicine. Increased maternal cardiovascular mortality associated with pregnancy in women with Turner syndrome. Fertil Steril. 2012;97(2):Art. no. 2. https:\/\/doi.org\/10.1016\/j.fertnstert.2011.11.049.","journal-title":"Fertil Steril"},{"issue":"4","key":"3197_CR51","doi-asserted-by":"publisher","first-page":"Art. no. 4","DOI":"10.1055\/s-0031-1280915","volume":"29","author":"SD Sullivan","year":"2011","unstructured":"Sullivan SD, Welt C, Sherman S. FMR1 and the continuum of primary ovarian insufficiency. Semin Reprod Med. 2011;29(4):Art. no. 4. https:\/\/doi.org\/10.1055\/s-0031-1280915.","journal-title":"Semin Reprod Med"},{"issue":"4","key":"3197_CR52","doi-asserted-by":"publisher","first-page":"Art. no. 4","DOI":"10.1007\/s10815-021-02067-7","volume":"38","author":"A La Marca","year":"2021","unstructured":"La Marca A, Mastellari E. Fertility preservation for genetic diseases leading to premature ovarian insufficiency (POI). J Assist Reprod Genet. 2021;38(4):Art. no. 4. https:\/\/doi.org\/10.1007\/s10815-021-02067-7.","journal-title":"J Assist Reprod Genet"},{"issue":"11","key":"3197_CR53","doi-asserted-by":"publisher","first-page":"Art. no. 11","DOI":"10.1007\/s10815-013-0079-x","volume":"30","author":"D Nayot","year":"2013","unstructured":"Nayot D, Chung JT, Son W-Y, Ao A, Hughes M, Dahan MH. Live birth following serial vitrification of embryos and PGD for fragile X syndrome in a patient with the premutation and decreased ovarian reserve. J Assist Reprod Genet. 2013;30(11):Art. no. 11. https:\/\/doi.org\/10.1007\/s10815-013-0079-x.","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"3197_CR54","doi-asserted-by":"publisher","first-page":"Art. no. 3","DOI":"10.1016\/j.fertnstert.2009.04.047","volume":"94","author":"G Bibi","year":"2010","unstructured":"Bibi G, et al. The effect of CGG repeat number on ovarian response among fragile X premutation carriers undergoing preimplantation genetic diagnosis. Fertil Steril. 2010;94(3):Art. no. 3. https:\/\/doi.org\/10.1016\/j.fertnstert.2009.04.047.","journal-title":"Fertil Steril"},{"issue":"9","key":"3197_CR55","doi-asserted-by":"publisher","first-page":"Art. no. 9","DOI":"10.1097\/GME.0000000000000658","volume":"23","author":"HS Hipp","year":"2016","unstructured":"Hipp HS, Charen KH, Spencer JB, Allen EG, Sherman SL. Reproductive and gynecologic care of women with fragile X primary ovarian insufficiency (FXPOI). Menopause N Y N. 2016;23(9):Art. no. 9. https:\/\/doi.org\/10.1097\/GME.0000000000000658.","journal-title":"Menopause N Y N"},{"issue":"6","key":"3197_CR56","doi-asserted-by":"publisher","first-page":"Art. no. 6","DOI":"10.1067\/mpd.2000.109148","volume":"137","author":"NV Guerrero","year":"2000","unstructured":"Guerrero NV, Singh RH, Manatunga A, Berry GT, Steiner RD, Elsas LJ. Risk factors for premature ovarian failure in females with galactosemia. J Pediatr. 2000;137(6):Art. no. 6. https:\/\/doi.org\/10.1067\/mpd.2000.109148.","journal-title":"J Pediatr"},{"issue":"5","key":"3197_CR57","doi-asserted-by":"publisher","first-page":"Art. no. 5","DOI":"10.1097\/OGX.0b013e31816ff6c5","volume":"63","author":"CS Gubbels","year":"2008","unstructured":"Gubbels CS, Land JA, Rubio-Gozalbo ME. Fertility and impact of pregnancies on the mother and child in classic galactosemia. Obstet Gynecol Surv. 2008;63(5):Art. no. 5. https:\/\/doi.org\/10.1097\/OGX.0b013e31816ff6c5.","journal-title":"Obstet Gynecol Surv"},{"issue":"1","key":"3197_CR58","doi-asserted-by":"publisher","first-page":"Art. no. 1","DOI":"10.1016\/j.fertnstert.2017.05.013","volume":"108","author":"B van Erven","year":"2017","unstructured":"van Erven B, et al. Fertility in adult women with classic galactosemia and primary ovarian insufficiency. Fertil Steril. 2017;108(1):Art. no. 1. https:\/\/doi.org\/10.1016\/j.fertnstert.2017.05.013.","journal-title":"Fertil Steril"},{"issue":"7","key":"3197_CR59","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s10815-018-1209-2","volume":"35","author":"LS Mamsen","year":"2018","unstructured":"Mamsen LS, Kelsey TW, Ernst E, Macklon KT, Lund AM, Andersen CY. Cryopreservation of ovarian tissue may be considered in young girls with galactosemia. J Assist Reprod Genet. 2018;35(7):1209\u201317. https:\/\/doi.org\/10.1007\/s10815-018-1209-2.","journal-title":"J Assist Reprod Genet"},{"issue":"1","key":"3197_CR60","doi-asserted-by":"publisher","first-page":"Art. no. 1","DOI":"10.1016\/j.fertnstert.2012.09.028","volume":"99","author":"Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology","year":"2013","unstructured":"Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: a guideline. Fertil Steril. 2013;99(1):Art. no. 1. https:\/\/doi.org\/10.1016\/j.fertnstert.2012.09.028.","journal-title":"Fertil Steril"},{"issue":"2","key":"3197_CR61","doi-asserted-by":"publisher","first-page":"Art. no. 2","DOI":"10.1016\/j.fertnstert.2018.10.014","volume":"111","author":"V Gunnala","year":"2019","unstructured":"Gunnala V, et al. BRCA carriers have similar reproductive potential at baseline to noncarriers: comparisons in cancer and cancer-free cohorts undergoing fertility preservation. Fertil Steril. 2019;111(2):Art. no. 2. https:\/\/doi.org\/10.1016\/j.fertnstert.2018.10.014.","journal-title":"Fertil Steril"},{"issue":"172","key":"3197_CR62","doi-asserted-by":"publisher","first-page":"172ra21","DOI":"10.1126\/scitranslmed.3004925","volume":"5","author":"S Titus","year":"2013","unstructured":"Titus S, et al. Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans. Sci Transl Med. 2013;5(172):172ra21. https:\/\/doi.org\/10.1126\/scitranslmed.3004925.","journal-title":"Sci Transl Med"},{"issue":"11","key":"3197_CR63","doi-asserted-by":"publisher","first-page":"Art. no. 11","DOI":"10.1093\/humrep\/dew242","volume":"31","author":"TC van Tilborg","year":"2016","unstructured":"van Tilborg TC, et al. Serum AMH levels in healthy women from BRCA1\/2 mutated families: are they reduced? Hum Reprod Oxf Engl. 2016;31(11):Art. no. 11. https:\/\/doi.org\/10.1093\/humrep\/dew242.","journal-title":"Hum Reprod Oxf Engl"},{"issue":"2","key":"3197_CR64","doi-asserted-by":"publisher","first-page":"Art. no. 2","DOI":"10.1093\/humrep\/dex356","volume":"33","author":"FA Peccatori","year":"2018","unstructured":"Peccatori FA, et al. Fertility preservation in women harboring deleterious BRCA mutations: ready for prime time? Hum Reprod Oxf Engl. 2018;33(2):Art. no. 2. https:\/\/doi.org\/10.1093\/humrep\/dex356.","journal-title":"Hum Reprod Oxf Engl"},{"key":"3197_CR65","doi-asserted-by":"publisher","unstructured":"European Society for Human Reproduction and Embryology (ESHRE) Guideline Group on POI, et al. ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod Oxf Engl. 2016; 31(5):Art. no. 5. https:\/\/doi.org\/10.1093\/humrep\/dew027.","DOI":"10.1093\/humrep\/dew027"},{"issue":"9744","key":"3197_CR66","doi-asserted-by":"publisher","first-page":"Art. no. 9744","DOI":"10.1016\/S0140-6736(10)60355-8","volume":"376","author":"M De Vos","year":"2010","unstructured":"De Vos M, Devroey P, Fauser BCJM. Primary ovarian insufficiency. Lancet Lond Engl. 2010;376(9744):Art. no. 9744. https:\/\/doi.org\/10.1016\/S0140-6736(10)60355-8.","journal-title":"Lancet Lond Engl"},{"issue":"2","key":"3197_CR67","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.fertnstert.2015.10.026","volume":"105","author":"JO Doyle","year":"2016","unstructured":"Doyle JO, Richter KS, Lim J, Stillman RJ, Graham JR, Tucker MJ. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval. Fertil Steril. 2016;105(2):459-466.e2. https:\/\/doi.org\/10.1016\/j.fertnstert.2015.10.026.","journal-title":"Fertil Steril"},{"issue":"3","key":"3197_CR68","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/humrep\/deu353","volume":"30","author":"N Suzuki","year":"2015","unstructured":"Suzuki N, et al. Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency. Hum Reprod Oxf Engl. 2015;30(3):608\u201315. https:\/\/doi.org\/10.1093\/humrep\/deu353.","journal-title":"Hum Reprod Oxf Engl"},{"issue":"4","key":"3197_CR69","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/MOP.0000000000000236","volume":"27","author":"CM Gordon","year":"2015","unstructured":"Gordon CM, Kanaoka T, Nelson LM. Update on primary ovarian insufficiency in adolescents. Curr Opin Pediatr. 2015;27(4):511\u20139. https:\/\/doi.org\/10.1097\/MOP.0000000000000236.","journal-title":"Curr Opin Pediatr"},{"issue":"3","key":"3197_CR70","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s42000-019-00141-5","volume":"19","author":"L Michala","year":"2020","unstructured":"Michala L, Stefanaki K, Loutradis D. Premature ovarian insufficiency in adolescence: a chance for early diagnosis? Horm Athens Greece. 2020;19(3):277\u201383. https:\/\/doi.org\/10.1007\/s42000-019-00141-5.","journal-title":"Horm Athens Greece"},{"issue":"1","key":"3197_CR71","doi-asserted-by":"publisher","first-page":"Art. no. 1","DOI":"10.1016\/j.fertnstert.2022.09.027","volume":"119","author":"L Verrilli","year":"2023","unstructured":"Verrilli L, Johnstone E, Welt C, Allen-Brady K. Primary ovarian insufficiency has strong familiality: results of a multigenerational genealogical study. Fertil Steril. 2023;119(1):Art. no. 1. https:\/\/doi.org\/10.1016\/j.fertnstert.2022.09.027.","journal-title":"Fertil Steril"},{"issue":"4","key":"3197_CR72","doi-asserted-by":"publisher","first-page":"Art. no. 4","DOI":"10.1016\/j.fertnstert.2021.12.023","volume":"117","author":"A Rouen","year":"2022","unstructured":"Rouen A, et al. Whole exome sequencing in a cohort of familial premature ovarian insufficiency cases reveals a broad array of pathogenic or likely pathogenic variants in 50% of families. Fertil Steril. 2022;117(4):Art. no. 4. https:\/\/doi.org\/10.1016\/j.fertnstert.2021.12.023.","journal-title":"Fertil Steril"},{"issue":"3","key":"3197_CR73","doi-asserted-by":"publisher","first-page":"Art. no. 3","DOI":"10.22074\/ijfs.2019.5599","volume":"13","author":"R Venturella","year":"2019","unstructured":"Venturella R, et al. The genetics of non-syndromic primary ovarian insufficiency: a systematic review. Int J Fertil Steril. 2019;13(3):Art. no. 3. https:\/\/doi.org\/10.22074\/ijfs.2019.5599.","journal-title":"Int J Fertil Steril"},{"key":"3197_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.664645","volume":"12","author":"R Rossetti","year":"2021","unstructured":"Rossetti R, et al. Targeted next-generation sequencing indicates a frequent oligogenic involvement in primary ovarian insufficiency onset. Front Endocrinol. 2021;12: 664645. https:\/\/doi.org\/10.3389\/fendo.2021.664645.","journal-title":"Front Endocrinol"},{"issue":"7","key":"3197_CR75","doi-asserted-by":"publisher","first-page":"Art. no. 7","DOI":"10.1210\/jendso\/bvab032","volume":"5","author":"S Eskenazi","year":"2021","unstructured":"Eskenazi S, et al. Next generation sequencing should be proposed to every woman with \u201cidiopathic\u201d primary ovarian insufficiency. J Endocr Soc. 2021;5(7):Art. no. 7. https:\/\/doi.org\/10.1210\/jendso\/bvab032.","journal-title":"J Endocr Soc"},{"issue":"1","key":"3197_CR76","doi-asserted-by":"publisher","first-page":"Art. no. 1","DOI":"10.1016\/j.fertnstert.2009.02.043","volume":"94","author":"M Rosendahl","year":"2010","unstructured":"Rosendahl M, Andersen CY, la Cour Freiesleben N, Juul A, L\u00f8ssl K, Andersen AN. Dynamics and mechanisms of chemotherapy-induced ovarian follicular depletion in women of fertile age. Fertil Steril. 2010;94(1):Art. no. 1. https:\/\/doi.org\/10.1016\/j.fertnstert.2009.02.043.","journal-title":"Fertil Steril"},{"issue":"6","key":"3197_CR77","doi-asserted-by":"publisher","first-page":"Art. no. 6","DOI":"10.1093\/humrep\/dez047","volume":"34","author":"C Poirot","year":"2019","unstructured":"Poirot C, et al. Impact of cancer chemotherapy before ovarian cortex cryopreservation on ovarian tissue transplantation. Hum Reprod Oxf Engl. 2019;34(6):Art. no. 6. https:\/\/doi.org\/10.1093\/humrep\/dez047.","journal-title":"Hum Reprod Oxf Engl"},{"issue":"3","key":"3197_CR78","doi-asserted-by":"publisher","first-page":"Art. no. 3","DOI":"10.1093\/humrep\/dead013","volume":"38","author":"M Devos","year":"2023","unstructured":"Devos M, Diaz Vidal P, Bouziotis J, Anckaert E, Dolmans M-M, Demeestere I. Impact of first chemotherapy exposure on follicle activation and survival in human cryopreserved ovarian tissue. Hum Reprod Oxf Engl. 2023;38(3):Art. no. 3. https:\/\/doi.org\/10.1093\/humrep\/dead013.","journal-title":"Hum Reprod Oxf Engl"},{"issue":"9","key":"3197_CR79","doi-asserted-by":"publisher","first-page":"Art. no. 9","DOI":"10.1093\/humrep\/dez125","volume":"34","author":"V Pampanini","year":"2019","unstructured":"Pampanini V, et al. Impact of first-line cancer treatment on the follicle quality in cryopreserved ovarian samples from girls and young women. Hum Reprod Oxf Engl. 2019;34(9):Art. no. 9. https:\/\/doi.org\/10.1093\/humrep\/dez125.","journal-title":"Hum Reprod Oxf Engl"},{"issue":"5","key":"3197_CR80","doi-asserted-by":"publisher","first-page":"Art. no. 5","DOI":"10.1093\/humrep\/deac035","volume":"37","author":"L Arecco","year":"2022","unstructured":"Arecco L, et al. Safety of fertility preservation techniques before and after anticancer treatments in young women with breast cancer: a systematic review and meta-analysis. Hum Reprod Oxf Engl. 2022;37(5):Art. no. 5. https:\/\/doi.org\/10.1093\/humrep\/deac035.","journal-title":"Hum Reprod Oxf Engl"},{"issue":"29","key":"3197_CR81","doi-asserted-by":"publisher","first-page":"Art. no. 29","DOI":"10.1200\/JCO.21.00535","volume":"39","author":"M Lambertini","year":"2021","unstructured":"Lambertini M, et al. Pregnancy after breast cancer: a systematic review and meta-analysis. J Clin Oncol Off J Am Soc Clin Oncol. 2021;39(29):Art. no. 29. https:\/\/doi.org\/10.1200\/JCO.21.00535.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"3197_CR82","doi-asserted-by":"publisher","first-page":"682060","DOI":"10.3389\/fcell.2021.682060","volume":"9","author":"W Yang","year":"2021","unstructured":"Yang W, et al. cyclophosphamide exposure causes long-term detrimental effect of oocytes developmental competence through affecting the epigenetic modification and maternal factors\u2019 transcription during oocyte growth. Front Cell Dev Biol. 2021;9:682060. https:\/\/doi.org\/10.3389\/fcell.2021.682060.","journal-title":"Front Cell Dev Biol"},{"issue":"12","key":"3197_CR83","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/j.annonc.2020.09.006","volume":"31","author":"M Lambertini","year":"2020","unstructured":"Lambertini M, et al. Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines\u2020. Ann Oncol Off J Eur Soc Med Oncol. 2020;31(12):1664\u201378. https:\/\/doi.org\/10.1016\/j.annonc.2020.09.006.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"1","key":"3197_CR84","doi-asserted-by":"publisher","first-page":"Art. no. 1","DOI":"10.1016\/j.fertnstert.2019.09.012","volume":"113","author":"A Vaiarelli","year":"2020","unstructured":"Vaiarelli A, et al. Luteal phase after conventional stimulation in the same ovarian cycle might improve the management of poor responder patients fulfilling the Bologna criteria: a case series. Fertil Steril. 2020;113(1):Art. no. 1. https:\/\/doi.org\/10.1016\/j.fertnstert.2019.09.012.","journal-title":"Fertil Steril"},{"issue":"1","key":"3197_CR85","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12958-022-00996-1","volume":"20","author":"I-J Yang","year":"2022","unstructured":"Yang I-J, et al. Usage and cost-effectiveness of elective oocyte freezing: a retrospective observational study. Reprod Biol Endocrinol RBE. 2022;20(1):123. https:\/\/doi.org\/10.1186\/s12958-022-00996-1.","journal-title":"Reprod Biol Endocrinol RBE"},{"issue":"2","key":"3197_CR86","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.rbmo.2019.11.010","volume":"40","author":"A Wafi","year":"2020","unstructured":"Wafi A, Nekkebroeck J, Blockeel C, De Munck N, Tournaye H, De Vos M. A follow-up survey on the reproductive intentions and experiences of women undergoing planned oocyte cryopreservation. Reprod Biomed Online. 2020;40(2):207\u201314. https:\/\/doi.org\/10.1016\/j.rbmo.2019.11.010.","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"3197_CR87","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/humrep\/dead267","volume":"39","author":"S Loreti","year":"2024","unstructured":"Loreti S, et al. A 10-year follow-up of reproductive outcomes in women attempting motherhood after elective oocyte cryopreservation. Hum Reprod Oxf Engl. 2024;39(2):355\u201363. https:\/\/doi.org\/10.1093\/humrep\/dead267.","journal-title":"Hum Reprod Oxf Engl"},{"issue":"12","key":"3197_CR88","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1093\/humrep\/dey321","volume":"33","author":"A Cobo","year":"2018","unstructured":"Cobo A, Garc\u00eda-Velasco J, Domingo J, Pellicer A, Remoh\u00ed J. Elective and onco-fertility preservation: factors related to IVF outcomes. Hum Reprod Oxf Engl. 2018;33(12):2222\u201331. https:\/\/doi.org\/10.1093\/humrep\/dey321.","journal-title":"Hum Reprod Oxf Engl"},{"issue":"1","key":"3197_CR89","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.fertnstert.2014.03.052","volume":"102","author":"PE Levi Setti","year":"2014","unstructured":"Levi Setti PE, et al. Human oocyte cryopreservation with slow freezing versus vitrification. Results from the National Italian Registry data, 2007\u20132011. Fertil Steril. 2014;102(1):90-95.e2. https:\/\/doi.org\/10.1016\/j.fertnstert.2014.03.052.","journal-title":"Fertil Steril"},{"issue":"3","key":"3197_CR90","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/humrep\/dead273","volume":"39","author":"L Mostinckx","year":"2024","unstructured":"Mostinckx L, et al. Clinical outcomes from ART in predicted hyperresponders: in vitro maturation of oocytes versus conventional ovarian stimulation for IVF\/ICSI. Hum Reprod Oxf Engl. 2024;39(3):586\u201394. https:\/\/doi.org\/10.1093\/humrep\/dead273.","journal-title":"Hum Reprod Oxf Engl"},{"issue":"4","key":"3197_CR91","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.annonc.2020.01.005","volume":"31","author":"M Grynberg","year":"2020","unstructured":"Grynberg M, Mayeur Le Bras A, Hesters L, Gallot V, Frydman N. First birth achieved after fertility preservation using vitrification of in vitro matured oocytes in a woman with breast cancer. Ann Oncol Off J Eur Soc Med Oncol. 2020;31(4):541\u20132. https:\/\/doi.org\/10.1016\/j.annonc.2020.01.005.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"12","key":"3197_CR92","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1007\/s10815-023-02932-7","volume":"40","author":"S Gayete-Lafuente","year":"2023","unstructured":"Gayete-Lafuente S, Turan V, Oktay KH. Oocyte cryopreservation with in vitro maturation for fertility preservation in girls at risk for ovarian insufficiency. J Assist Reprod Genet. 2023;40(12):2777\u201385. https:\/\/doi.org\/10.1007\/s10815-023-02932-7.","journal-title":"J Assist Reprod Genet"},{"issue":"2","key":"3197_CR93","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10815-019-01677-6","volume":"37","author":"LN Vuong","year":"2020","unstructured":"Vuong LN, et al. Live births after oocyte in vitro maturation with a prematuration step in women with polycystic ovary syndrome. J Assist Reprod Genet. 2020;37(2):347\u201357. https:\/\/doi.org\/10.1007\/s10815-019-01677-6.","journal-title":"J Assist Reprod Genet"},{"issue":"2","key":"3197_CR94","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/humrep\/deab243","volume":"37","author":"X Zheng","year":"2022","unstructured":"Zheng X, et al. In vitro maturation without gonadotropins versus in vitro fertilization with hyperstimulation in women with polycystic ovary syndrome: a non-inferiority randomized controlled trial. Hum Reprod Oxf Engl. 2022;37(2):242\u201353. https:\/\/doi.org\/10.1093\/humrep\/deab243.","journal-title":"Hum Reprod Oxf Engl"},{"issue":"5","key":"3197_CR95","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/aogs.13559","volume":"98","author":"KA Rodriguez-Wallberg","year":"2019","unstructured":"Rodriguez-Wallberg KA, et al. A prospective study of women and girls undergoing fertility preservation due to oncologic and non-oncologic indications in Sweden-Trends in patients\u2019 choices and benefit of the chosen methods after long-term follow up. Acta Obstet Gynecol Scand. 2019;98(5):604\u201315. https:\/\/doi.org\/10.1111\/aogs.13559.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"15","key":"3197_CR96","doi-asserted-by":"publisher","first-page":"8088","DOI":"10.3390\/ijerph18158088","volume":"18","author":"VN Varlas","year":"2021","unstructured":"Varlas VN, et al. Social freezing: pressing pause on fertility. Int J Environ Res Public Health. 2021;18(15):8088. https:\/\/doi.org\/10.3390\/ijerph18158088.","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"3197_CR97","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s10815-016-0669-5","volume":"33","author":"B Luke","year":"2016","unstructured":"Luke B, et al. Embryo banking among women diagnosed with cancer: a pilot population-based study in New York, Texas, and Illinois. J Assist Reprod Genet. 2016;33(5):667\u201374. https:\/\/doi.org\/10.1007\/s10815-016-0669-5.","journal-title":"J Assist Reprod Genet"},{"issue":"6","key":"3197_CR98","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.fertnstert.2019.09.013","volume":"112","author":"Practice Committee of the American Society for Reproductive Medicine. Electronic address: asrm@asrm.org","year":"2019","unstructured":"Practice Committee of the American Society for Reproductive Medicine. Electronic address: asrm@asrm.org. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2019;112(6):1022\u201333. https:\/\/doi.org\/10.1016\/j.fertnstert.2019.09.013.","journal-title":"Fertil Steril"},{"issue":"3","key":"3197_CR99","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/humupd\/dmac003","volume":"28","author":"H Khattak","year":"2022","unstructured":"Khattak H, et al. Fresh and cryopreserved ovarian tissue transplantation for preserving reproductive and endocrine function: a systematic review and individual patient data meta-analysis. Hum Reprod Update. 2022;28(3):400\u201316. https:\/\/doi.org\/10.1093\/humupd\/dmac003.","journal-title":"Hum Reprod Update"},{"issue":"9","key":"3197_CR100","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1093\/humrep\/deaa175","volume":"35","author":"I Segers","year":"2020","unstructured":"Segers I, et al. Live births following fertility preservation using in-vitro maturation of ovarian tissue oocytes. Hum Reprod Oxf Engl. 2020;35(9):2026\u201336. https:\/\/doi.org\/10.1093\/humrep\/deaa175.","journal-title":"Hum Reprod Oxf Engl"},{"issue":"9","key":"3197_CR101","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1093\/humrep\/deab180","volume":"36","author":"C Massarotti","year":"2021","unstructured":"Massarotti C, et al. #ESHREjc report: is OTO-IVM the future fertility preservation alternative for urgent cancer patients? Hum Reprod Oxf Engl. 2021;36(9):2631\u20133. https:\/\/doi.org\/10.1093\/humrep\/deab180.","journal-title":"Hum Reprod Oxf Engl"},{"issue":"3","key":"3197_CR102","doi-asserted-by":"publisher","first-page":"Art. no. 3","DOI":"10.1093\/humrep\/deac249","volume":"38","author":"E Fraison","year":"2023","unstructured":"Fraison E, et al. Live birth rate after female fertility preservation for cancer or haematopoietic stem cell transplantation: a systematic review and meta-analysis of the three main techniques; embryo, oocyte and ovarian tissue cryopreservation. Hum Reprod Oxf Engl. 2023;38(3):Art. no. 3. https:\/\/doi.org\/10.1093\/humrep\/deac249.","journal-title":"Hum Reprod Oxf Engl"},{"issue":"23","key":"3197_CR103","doi-asserted-by":"publisher","first-page":"5873","DOI":"10.3390\/cancers14235873","volume":"14","author":"LB Colmorn","year":"2022","unstructured":"Colmorn LB, et al. Reproductive and endocrine outcomes in a cohort of Danish women following auto-transplantation of frozen\/thawed ovarian tissue from a single center. Cancers. 2022;14(23):5873. https:\/\/doi.org\/10.3390\/cancers14235873.","journal-title":"Cancers"},{"issue":"3","key":"3197_CR104","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.fertnstert.2017.11.018","volume":"109","author":"C Diaz-Garcia","year":"2018","unstructured":"Diaz-Garcia C, et al. Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study. Fertil Steril. 2018;109(3):478-485.e2. https:\/\/doi.org\/10.1016\/j.fertnstert.2017.11.018.","journal-title":"Fertil Steril"},{"issue":"5","key":"3197_CR105","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.rbmo.2019.01.006","volume":"38","author":"J Liebenthron","year":"2019","unstructured":"Liebenthron J, et al. Overnight ovarian tissue transportation for centralized cryobanking: a feasible option. Reprod Biomed Online. 2019;38(5):740\u20139. https:\/\/doi.org\/10.1016\/j.rbmo.2019.01.006.","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"3197_CR106","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00404-009-1224-8","volume":"281","author":"J Ott","year":"2010","unstructured":"Ott J, et al. Ovarian tissue cryopreservation for non-malignant indications. Arch Gynecol Obstet. 2010;281(4):735\u20139. https:\/\/doi.org\/10.1007\/s00404-009-1224-8.","journal-title":"Arch Gynecol Obstet"},{"issue":"6","key":"3197_CR107","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s10815-023-02792-1","volume":"40","author":"A Vaiarelli","year":"2023","unstructured":"Vaiarelli A, et al. Clinical and laboratory key performance indicators in IVF: a consensus between the Italian Society of Fertility and Sterility and Reproductive Medicine (SIFES-MR) and the Italian Society of Embryology, Reproduction and Research (SIERR). J Assist Reprod Genet. 2023;40(6):1479\u201394. https:\/\/doi.org\/10.1007\/s10815-023-02792-1.","journal-title":"J Assist Reprod Genet"},{"issue":"5","key":"3197_CR108","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.rbmo.2017.06.015","volume":"35","author":"ESHRE Special Interest Group of Embryology and Alpha Scientists in Reproductive Medicine. Electronic address: coticchio.biogenesi@grupposandonato.it","year":"2017","unstructured":"ESHRE Special Interest Group of Embryology and Alpha Scientists in Reproductive Medicine. Electronic address: coticchio.biogenesi@grupposandonato.it. The Vienna consensus: report of an expert meeting on the development of ART laboratory performance indicators. Reprod Biomed Online. 2017;35(5):494\u2013510. https:\/\/doi.org\/10.1016\/j.rbmo.2017.06.015.","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"3197_CR109","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.rbmo.2012.05.006","volume":"25","author":"Alpha Scientists in Reproductive Medicine","year":"2012","unstructured":"Alpha Scientists in Reproductive Medicine. The Alpha consensus meeting on cryopreservation key performance indicators and benchmarks: proceedings of an expert meeting. Reprod Biomed Online. 2012;25(2):146\u201367. https:\/\/doi.org\/10.1016\/j.rbmo.2012.05.006.","journal-title":"Reprod Biomed Online"},{"key":"3197_CR110","doi-asserted-by":"publisher","unstructured":"ESHRE Clinic PI Working Group, et al. The Maribor consensus: report of an expert meeting on the development of performance indicators for clinical practice in ART. Hum Reprod Open. 2021;2021(3): hoab022. https:\/\/doi.org\/10.1093\/hropen\/hoab022.","DOI":"10.1093\/hropen\/hoab022"},{"issue":"4","key":"3197_CR111","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.rbmo.2021.06.024","volume":"43","author":"AQ Leung","year":"2021","unstructured":"Leung AQ, et al. Clinical outcomes and utilization from over a decade of planned oocyte cryopreservation. Reprod Biomed Online. 2021;43(4):671\u20139. https:\/\/doi.org\/10.1016\/j.rbmo.2021.06.024.","journal-title":"Reprod Biomed Online"},{"issue":"9","key":"3197_CR112","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1093\/humrep\/deu137","volume":"29","author":"T Dahhan","year":"2014","unstructured":"Dahhan T, Dancet EAF, Miedema DV, van der Veen F, Goddijn M. Reproductive choices and outcomes after freezing oocytes for medical reasons: a follow-up study. Hum Reprod Oxf Engl. 2014;29(9):1925\u201330. https:\/\/doi.org\/10.1093\/humrep\/deu137.","journal-title":"Hum Reprod Oxf Engl"},{"issue":"6","key":"3197_CR113","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1016\/j.fertnstert.2015.02.029","volume":"103","author":"K Devine","year":"2015","unstructured":"Devine K, et al. Baby budgeting: oocyte cryopreservation in women delaying reproduction can reduce cost per live birth. Fertil Steril. 2015;103(6):1446-1453.e1-2. https:\/\/doi.org\/10.1016\/j.fertnstert.2015.02.029.","journal-title":"Fertil Steril"},{"issue":"6","key":"3197_CR114","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/j.fertnstert.2021.07.1195","volume":"116","author":"LE Caughey","year":"2021","unstructured":"Caughey LE, Lensen S, White KM, Peate M. Disposition intentions of elective egg freezers toward their surplus frozen oocytes: a systematic review and meta-analysis. Fertil Steril. 2021;116(6):1601\u201319. https:\/\/doi.org\/10.1016\/j.fertnstert.2021.07.1195.","journal-title":"Fertil Steril"},{"key":"3197_CR115","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1749-6632.2010.05527.x","volume":"1204","author":"K Hawkes","year":"2010","unstructured":"Hawkes K, Smith KR. Do women stop early? Similarities in fertility decline in humans and chimpanzees. Ann N Y Acad Sci. 2010;1204:43\u201353. https:\/\/doi.org\/10.1111\/j.1749-6632.2010.05527.x.","journal-title":"Ann N Y Acad Sci"},{"issue":"4771","key":"3197_CR116","doi-asserted-by":"publisher","first-page":"Art. no. 4771","DOI":"10.1126\/science.3755843","volume":"233","author":"J Menken","year":"1986","unstructured":"Menken J, Trussell J, Larsen U. Age and infertility. Science. 1986;233(4771):Art. no. 4771. https:\/\/doi.org\/10.1126\/science.3755843.","journal-title":"Science"},{"issue":"5","key":"3197_CR117","doi-asserted-by":"publisher","first-page":"Art. no. 5","DOI":"10.2307\/2134890","volume":"14","author":"GE Hendershot","year":"1982","unstructured":"Hendershot GE, Mosher WD, Pratt WF. Infertility and age: an unresolved issue. Fam Plann Perspect. 1982;14(5):Art. no. 5.","journal-title":"Fam Plann Perspect"},{"issue":"5","key":"3197_CR118","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.fertnstert.2021.02.006","volume":"115","author":"A Cobo","year":"2021","unstructured":"Cobo A, Garc\u00eda-Velasco JA, Remoh\u00ed J, Pellicer A. Oocyte vitrification for fertility preservation for both medical and nonmedicalreasons. Fertil Steril. 2021;115(5):1091\u2013101. https:\/\/doi.org\/10.1016\/j.fertnstert.2021.02.006.","journal-title":"Fertil Steril"},{"issue":"4","key":"3197_CR119","doi-asserted-by":"publisher","first-page":"100885","DOI":"10.1016\/j.ajogmf.2023.100885","volume":"5","author":"S Sugai","year":"2023","unstructured":"Sugai S, Nishijima K, Haino K, Yoshihara K. Pregnancy outcomes at maternal age over 45 years: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2023;5(4):100885. https:\/\/doi.org\/10.1016\/j.ajogmf.2023.100885.","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"1","key":"3197_CR120","doi-asserted-by":"publisher","first-page":"e2349722","DOI":"10.1001\/jamanetworkopen.2023.49722","volume":"7","author":"Y Fouks","year":"2024","unstructured":"Fouks Y, Sakkas D, Bortoletto PE, Penzias AS, Seidler EA, Vaughan DA. Utilization of cryopreserved oocytes in patients with poor ovarian response after planned oocyte cryopreservation. JAMA Netw Open. 2024;7(1):e2349722. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.49722.","journal-title":"JAMA Netw Open"},{"issue":"6","key":"3197_CR121","doi-asserted-by":"publisher","first-page":"Art. no. 6","DOI":"10.2196\/25083","volume":"5","author":"A Hoffman","year":"2021","unstructured":"Hoffman A, et al. Patients\u2019 and Providers\u2019 needs and preferences when considering fertility preservation before cancer treatment: decision-making needs assessment. JMIR Form Res. 2021;5(6):Art. no. 6. https:\/\/doi.org\/10.2196\/25083.","journal-title":"JMIR Form Res"},{"issue":"1","key":"3197_CR122","doi-asserted-by":"publisher","first-page":"Art. no. 1","DOI":"10.1186\/s12905-023-02189-3","volume":"23","author":"L Drost","year":"2023","unstructured":"Drost L, et al. Patients\u2019 and providers\u2019 perspectives on non-urgent egg freezing decision-making: a thematic analysis. BMC Womens Health. 2023;23(1):Art. no. 1. https:\/\/doi.org\/10.1186\/s12905-023-02189-3.","journal-title":"BMC Womens Health"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-024-03197-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-024-03197-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-024-03197-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T07:17:57Z","timestamp":1726471077000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10815-024-03197-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,20]]},"references-count":122,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["3197"],"URL":"https:\/\/doi.org\/10.1007\/s10815-024-03197-4","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,20]]},"assertion":[{"value":"9 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare to have no conflicts of interest related to the present paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}}]}}